Production of specific mRNA transcripts, usage of an alternate promoter, and octamer-binding transcription factors influence the surface expression levels of the HIV coreceptor CCR5 on primary T cells

Journal of Immunology

Volumn 178, Issue 9, 2007, Pages 5668-5681

  Mummidi, Srinivas ^a   Adams, Lisa M ^a   VanCompernolle, Scott E ^b   Kalkonde, Mrunal ^a   Camargo, Jose F ^a   Kulkarni, Hemant ^a   Bellinger, Adam S ^a   Bonello, Gregory ^a   Tagoh, Hiromi ^a,c   Ahuja, Seema S ^a   Unutmaz, Derya ^d   Ahuja, Sunil K ^a,e  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; HISTONE H3; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CD4+ T LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EXON; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENOMICS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION SENSITIVITY; LEUKEMIA CELL LINE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRUS IMMUNITY;

EID: 34247640675     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.9.5668     Document Type: Article

References (57)

1. Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17: 657-700.
2. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinghoff, E. Gomperts, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene: Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273: 1856-1862.
3. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stuhlmann, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367-377.
4. Naif, H. M., S. Li, M. Alali, A. Sloane, L. Wu, M. Kelly, G. Lynch, A. Lloyd, and A. L. Cunningham. 1998. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J. Virol. 72: 830-836.
5. Platt, E. J., K. Wehrly, S. E. Kuhmann, B. Chesebro, and D. Kabat. 1998. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72: 2855-2864.
6. Reynes, J., P. Portales, M. Segondy, V. Baillat, P. Andre, O. Avinens, M. C. Picot, J. Clot, J. F. Eliaou, and P. Corbeau. 2001. CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression. AIDS 15: 1627-1634.
7. + T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1. J. Infect. Dis. 181: 927-932.
8. Tuttle, D. L., J. K. Harrison, C. Anders, J. W. Sleasman, and M. M. Goodenow. 1998. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J. Virol. 72: 4962-4969.
9. Wu, L., W. A. Paxton, N. Kassam, N. Ruffing, J. B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, R. A. Koup, and C. R. Mackay. 1997. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185: 1681-1691.
10. Mummidi, S., S. S. Ahuja, B. L. McDaniel, and S. K. Ahuja. 1997. The human CC chemokine receptor 5 (CCR5) gene: multiple transcripts with 5′-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons. J. Biol. Chem. 272: 30662-30671.
11. Mummidi, S., M. Bamshad, S. S. Ahuja, E. Gonzalez, P. M. Feuillet, K. Begum, M. C. Galvis, V. Kostecki, A. J. Valente, K. K. Murthy, et al. 2000. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA: potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J. Biol. Chem. 275: 18946-18961.
12. Guignard, F., C. Combadiere, H. L. Tiffany, and P. M. Murphy. 1998. Gene organization and promoter function for CC chemokine receptor 5 (CCR5). J. Immunol. 160: 985-992.
13. Liu, R., X. Zhao, T. A. Gurney, and N. R. Landau. 1998. Functional analysis of the proximal CCR5 promoter. AIDS Res. Hum. Retroviruses 14: 1509-1519.
14. Moriuchi, H., M. Moriuchi, and A. S. Fauci. 1997. Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. J. Immunol. 159: 5441-5449.
15. Bream, J. H., H. A. Young, N. Rice, M. P. Martin, M. W. Smith, M. Carrington, and S. J. O'Brien. 1999. CCR5 promoter alleles and specific DNA binding factors. Science 284: 223.
16. Moriuchi, M., and H. Moriuchi. 2001. Octamer transcription factors up-regulate the expression of CCR5, a coreceptor for HIV-1 entry. J. Biol. Chem. 276: 8639-8642.
17. Moriuchi, M., H. Moriuchi, and A. S. Fauci. 1999. GATA-1 transcription factor transactivates the promoter for CCR5, a coreceptor for human immunodeficiency virus type 1 entry. Blood 93: 1433-1435.
18. Rosati, M., A. Valentin, D. J. Patenaude, and G. N. Pavlakis. 2001. CCAAT-enhancer-binding protein β (C/EBP β) activates CCR5 promoter: increased C/EBP β and CCR5 in T lymphocytes from HIV-1-infected individuals. J. Immunol 167: 1654-1662.
19. Mummidi, S., S. S. Ahuja, E. Gonzalez, S. A. Anderson, E. N. Santiago, K. T. Stephan, F. E. Craig, P. O'Connell, V. Tryon, R. A. Clark, et al. 1998. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat. Med. 4: 786-793.
20. Gonzalez, E., M. Bamshad, N. Sato, S. Mummidi, R. Dhanda, G. Catano, S. Cabrera, M. McBride, X. H. Cao, G. Merrill, et al. 1999. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc. Natl. Acad. Sci. USA 96: 12004-12009.
21. Mangano, A., E. Gonzalez, R. Dhanda, G. Catano, M. Bamshad, A. Bock, R. Duggirala, K. Williams, S. Mummidi, R. A. Clark, et al. 2001. Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus. J. Infect. Dis. 183: 1574-1585.
22. Martin, M. P., M. Dean, M. W. Smith, C. Winkler, B. Gerrard, N. L. Michael, B. Lee, R. W. Doms, J. Margolick, S. Buchbinder, et al. 1998. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282: 1907-1911.
23. O'Brien, S. J., and J. P. Moore. 2000. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol. Rev. 177: 99-111.
24. McDermott, D. H., P. A. Zimmerman, F. Guignard, C. A. Kleeberger, S. F. Leitman, and P. M. Murphy. 1998. CCR5 promoter polymorphism and HIV-1 disease progression: Multicenter AIDS Cohort Study (MACS). Lancet 352: 866-870.
25. Oswald-Richter, K., S. M. Grill, N. Shariat, M. Leelawong, M. S. Sundrud, D. W. Haas, and D. Unutmaz. 2004. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2: E198.
26. Unutmaz, D., V. N. KewalRamani, S. Marmon, and D. R. Littman. 1999. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189: 1735-1746.
27. Mummidi, S., G. Catano, L. Lam, A. Hoefle, V. Telles, K. Begum, F. Jimenez, S. S. Ahuja, and S. K. Ahuja. 2001. Extensive repertoire of membrane-bound and soluble dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2 isoforms: inter-individual variation in expression of DC-SIGN transcripts. J. Biol. Chem. 276: 33196-33212.
28. + T cells. J. Clin. Immunol. 21: 116-125.
29. Creson, J. R., A. A. Lin, Q. Li, D. F. Broad, M. R. Roberts, and S. J. Anderson. 1999. The mode and duration of anti-CD28 costimulation determine resistance to infection by macrophage-tropic strains of human immunodeficiency virus type 1 in vitro. J. Virol. 73: 9337-9347.
30. Motsinger, A., D. W. Haas, A. K. Stanic, L. Van Kaer, S. Joyce, and D. Unutmaz. 2002. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J. Exp. Med. 195: 869-879.
31. Rao, S., E. Procko, and M. F. Shannon. 2001. Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene. J. Immunol. 167: 4494-4503.
32. Kang, K. H., and S. H. Im. 2005. Differential regulation of the IL-10 gene In Th1 and Th2 T cells. Ann. NY Acad Sci. 1050: 97-107.
33. Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293: 1074-1080.
34. Kemler, I., E. Bucher, K. Seipel, M. M. Muller-Immergluck, and W. Schaffner. 1991. Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration. Nucleic Acids Res. 19: 237-242.
35. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269: 1727-1730.
36. Molon, B., G. Gri, M. Bettella, C. Gomez-Mouton, A. Lanzavecchia, A. C. Martinez, S. Manes, and A. Viola. 2005. T cell costimulation by chemokine receptors. Nat. Immunol. 6: 465-471.
37. Taub, D. D., S. M. Turcovski-Corrales, M. L. Key, D. L. Longo, and W. J. Murphy. 1996. Chemokines and T lymphocyte activation: I. β chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156: 2095-2103.
38. Moser, B., and P. Loetscher. 2001. Lymphocyte traffic control by chemokines. Nat. Immunol. 2: 123-128.
39. Zou, W., V. Machelon, A. Coulomb-L'Hermin, J. Borvak, F. Nome, T. Isaeva, S. Wei, R. Krzysiek, I. Durand-Gasselin, A. Gordon, et al. 2001. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat. Med. 7: 1339-1346.
40. Karpus, W. J., N. W. Lukacs, K. J. Kennedy, W. S. Smith, S. D. Hurst, and T. A. Barrett. 1997. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 158: 4129-4136.
41. Lillard, J. W., Jr., U. P. Singh, P. N. Boyaka, S. Singh, D. D. Taub, and J. R. McGhee. 2003. MIP-1α and MIP-1β differentially mediate mucosal and systemic adaptive immunity. Blood 101: 807-814.
42. + T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
43. Newbound, G. C., J. P. O'Rourke, N. D. Collins, J. DeWille, and M. D. Lairmore. 1999. Comparison of HTLV-I basal transcription and expression of CREB/ATF-1/CREM family members in peripheral blood mononuclear cells and Jurkat T cells. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 20: 1-10.
44. Hughes, C. C., and J. S. Pober. 1996. Transcriptional regulation of the interleukin-2 gene in normal human peripheral blood T cells: convergence of costimulatory signals and differences from transformed T cells. J. Biol. Chem. 271: 5369-5377.
45. Roh, T. Y., S. Cuddapah, and K. Zhao. 2005. Active chromatin domains are defined by acetylafion islands revealed by genome-wide mapping. Genes Dev. 19: 542-552.
46. Konig, H., P. Pfisterer, L. M. Corcoran, and T. Wirth. 1995. Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2. Genes Dev. 9: 1598-1607.
47. Harada, H., K. Willison, J. Sakakibara, M. Miyamoto, T. Fujita, and T. Taniguchi. 1990. Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 63: 303-312.
48. Harada, H., T. Fujita, M. Miyamoto, Y. Kimura, M. Maruyama, A. Furia, T. Miyata, and T. Taniguchi. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729-739.
49. Descombes, P., and U. Schibler. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67: 569-579.
50. Cooper, C., A. Henderson, S. Artandi, N. Avitahl, and K. Calame. 1995. Ig/EBP (C/EBP γ) is a transdominant negative inhibitor of C/EBP family transcriptional activators. Nucleic Acids Res. 23: 4371-4377.
51. Cron, R. Q., B. Zhou, M. W. Brunvand, and D. B. Lewis. 2001. Octamer proteins inhibit IL-4 gene transcription in normal human CD4 T cells. Genes Immun. 2: 464-468.
52. de Grazia, U., M. P. Felli, A. Vacca, A. R. Farina, M. Maroder, L. Cappabianca, D. Meco, M. Farina, I. Screpanti, L. Frati, et al. 1994. Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor. J. Exp. Med. 180: 1485-1497.
53. Kamps, M. P., L. Corcoran, J. H. LeBowitz, and D. Baltimore. 1990. The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Mol. Cell. Biol. 10: 5464-5472.
54. Wolf, I., V. Pevzner, E. Kaiser, G. Bernhardt, E. Claudio, U. Siebenlist, R. Forster, and M. Lipp. 1998. Downstream activation of a TATA-less promoter by Oct-2, Bob1, and NF-κB directs expression of the homing receptor BLR1 to mature B cells. J. Biol. Chem 273: 28831-28836.
55. Yamamoto, K., H. Takeshima, K. Hamada, M. Nakao, T. Kino, T. Nishi, M. Kochi, J. Kuratsu, T. Yoshimura, and Y. Ushio. 1999. Cloning and functional characterization of the 5′-flanking region of the human monocyte chemoattractant protein-1 receptor (CCR2) gene: essential role of 5′-untranslated region in tissue-specific expression. J. Biol. Chem. 274: 4646-4654.
56. Giri, R. K., V. Rajagopal, and V. K. Kalra. 2004. Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J. Neurochem. 91: 1199-1210.
57. + T cells is a typical feature of natural SIV hosts. Blood 109: 1069-1076.